Archive for 'March,2013'

CluePoints holds official inauguration* of new office in Mont Saint Guibert and launches solution for risk-based monitoring using the SMART™ engine approach

CluePoints holds official inauguration* of new office in Mont Saint Guibert and launches solution for risk-based monitoring using the SMART™ engine approach

IDDI (International Drug Development Institute) has recently launched its subsidiary entitled CluePoints, the new software and service provider of Intelligent Statistical Monitoring Solutions. This exciting new development is a follow-up to the IDDI article published last [...]

Artialis’ biomarker technology provides early detection of joint disorders and effective monitoring of treatments, confirming Tilman’s plant based supplement offers effective treatment

Artialis’ biomarker technology provides early detection of joint disorders and effective monitoring of treatments, confirming Tilman’s plant based supplement offers effective treatment

Artialis(Liège) and Tilman(Baillonville), two Wallonia-based biotech companies specialized in joint disorders and medicinal plant therapy respectively, through combined efforts are making a name for themeselves with effective “natural” treatment of joint disorders. Everyone knows joints can [...]

Cardiatis (Isnes, Belgium) creates multilayer flow modulator stent offering non-invasive alternative for the treatment of a “Silent Killer”

Cardiatis (Isnes, Belgium) creates multilayer flow modulator stent offering non-invasive alternative for the treatment of a “Silent Killer”

Stemming from the idea of the continuous flow of jet induced fountains, Cardiatis CEO, Noureddine Frid, imagined that if the theory of “fluid mechanics” could be applied to converting turbulence to laminar flow in the blood [...]

Galephar opens new perspectives in the treatment of chronic respiratory infections

Galephar opens new perspectives in the treatment of chronic respiratory infections

  Galephar will soon launch phase 1 clinical trials to confirm the effectiveness of new inhaled synergetic combinations in the treatment of cystic fibrosis. Here lies yet another example of how Biowin, through its R & [...]

Thanks to interactions with the BioWin R & D projects, WOW Technology (Nannine, Belgium) continues to develop and produce innovative laboratory and medical devices

Thanks to interactions with the BioWin R & D projects, WOW Technology (Nannine, Belgium) continues to develop and produce innovative laboratory and medical devices

Continuing with our series of BioWin Success Stories, WOW Technology from the Wallonia region of Belgium, is getting a lot in return after providing their expertise for the BioLine* R & D project. Engineers at WOW [...]